RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 128 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.27 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,627,280 | +41.0% | 15,506,834 | +37.7% | 0.00% | +50.0% |
| Q2 2023 | $84,110,946 | +15.3% | 11,259,832 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $72,927,005 | -6.0% | 10,933,584 | +8.7% | 0.00% | 0.0% |
| Q4 2022 | $77,542,269 | -13.0% | 10,057,363 | +20.0% | 0.00% | -33.3% |
| Q3 2022 | $89,174,000 | +56.8% | 8,380,986 | +19.9% | 0.00% | +50.0% |
| Q2 2022 | $56,879,000 | +20.2% | 6,987,467 | +5.7% | 0.00% | +100.0% |
| Q1 2022 | $47,338,000 | -54.8% | 6,611,377 | +8.1% | 0.00% | -50.0% |
| Q4 2021 | $104,731,000 | +67.8% | 6,113,873 | +125.4% | 0.00% | 0.0% |
| Q3 2021 | $62,403,000 | -36.3% | 2,711,980 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $97,934,000 | – | 2,683,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 5,977,631 | $42,800,000 | 100.00% |
| Two Sigma Ventures, LP | 1,806,800 | $12,937,000 | 74.73% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $28,290,000 | 31.54% |
| MV Management XI, L.L.C. | 1,971,908 | $14,119,000 | 9.80% |
| Data Collective IV GP, LLC | 5,941,120 | $42,538,000 | 9.03% |
| ArchPoint Investors | 1,267,430 | $9,075,000 | 3.13% |
| MIC Capital Management UK LLP | 1,388,889 | $9,944,000 | 1.94% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $10,806,000 | 1.09% |
| Samsara BioCapital, LLC | 539,236 | $3,861,000 | 0.97% |
| Pinz Capital Management, LP | 142,168 | $1,018,000 | 0.64% |